Reperfusion Without Functional Independence in Late Presentation of Stroke With Large Vessel Occlusion.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 18 10 2022
medline: 1 12 2022
entrez: 17 10 2022
Statut: ppublish

Résumé

Reperfusion without functional independence (RFI) is an undesired outcome following thrombectomy in acute ischemic stroke. The primary objective was to evaluate, in patients presenting with proximal anterior circulation occlusion stroke in the extended time window, whether selection with computed tomography (CT) perfusion or magnetic resonance imaging is associated with RFI, mortality, or symptomatic intracranial hemorrhage (sICH) compared with noncontrast CT selected patients. The CLEAR study (CT for Late Endovascular Reperfusion) was a multicenter, retrospective cohort study of stroke patients undergoing thrombectomy in the extended time window. Inclusion criteria for this analysis were baseline National Institutes of Health Stroke Scale score ≥6, internal carotid artery, M1 or M2 segment occlusion, prestroke modified Rankin Scale score of 0 to 2, time-last-seen-well to treatment 6 to 24 hours, and successful reperfusion (modified Thrombolysis in Cerebral Infarction 2c-3). Of 2304 patients in the CLEAR study, 715 patients met inclusion criteria. Of these, 364 patients (50.9%) showed RFI (ie, mRS score of 3-6 at 90 days despite successful reperfusion), 37 patients (5.2%) suffered sICH, and 127 patients (17.8%) died within 90 days. Neither imaging selection modality for thrombectomy candidacy (noncontrast CT versus CT perfusion versus magnetic resonance imaging) was associated with RFI, sICH, or mortality. Older age, higher baseline National Institutes of Health Stroke Scale, higher prestroke disability, transfer to a comprehensive stroke center, and a longer interval to puncture were associated with RFI. The presence of M2 occlusion and higher baseline Alberta Stroke Program Early CT Score were inversely associated with RFI. Hypertension was associated with sICH. RFI is a frequent phenomenon in the extended time window. Neither magnetic resonance imaging nor CT perfusion selection for mechanical thrombectomy was associated with RFI, sICH, and mortality compared to noncontrast CT selection alone. URL: https://www. gov; Unique identifier: NCT04096248.

Sections du résumé

BACKGROUND
Reperfusion without functional independence (RFI) is an undesired outcome following thrombectomy in acute ischemic stroke. The primary objective was to evaluate, in patients presenting with proximal anterior circulation occlusion stroke in the extended time window, whether selection with computed tomography (CT) perfusion or magnetic resonance imaging is associated with RFI, mortality, or symptomatic intracranial hemorrhage (sICH) compared with noncontrast CT selected patients.
METHODS
The CLEAR study (CT for Late Endovascular Reperfusion) was a multicenter, retrospective cohort study of stroke patients undergoing thrombectomy in the extended time window. Inclusion criteria for this analysis were baseline National Institutes of Health Stroke Scale score ≥6, internal carotid artery, M1 or M2 segment occlusion, prestroke modified Rankin Scale score of 0 to 2, time-last-seen-well to treatment 6 to 24 hours, and successful reperfusion (modified Thrombolysis in Cerebral Infarction 2c-3).
RESULTS
Of 2304 patients in the CLEAR study, 715 patients met inclusion criteria. Of these, 364 patients (50.9%) showed RFI (ie, mRS score of 3-6 at 90 days despite successful reperfusion), 37 patients (5.2%) suffered sICH, and 127 patients (17.8%) died within 90 days. Neither imaging selection modality for thrombectomy candidacy (noncontrast CT versus CT perfusion versus magnetic resonance imaging) was associated with RFI, sICH, or mortality. Older age, higher baseline National Institutes of Health Stroke Scale, higher prestroke disability, transfer to a comprehensive stroke center, and a longer interval to puncture were associated with RFI. The presence of M2 occlusion and higher baseline Alberta Stroke Program Early CT Score were inversely associated with RFI. Hypertension was associated with sICH.
CONCLUSIONS
RFI is a frequent phenomenon in the extended time window. Neither magnetic resonance imaging nor CT perfusion selection for mechanical thrombectomy was associated with RFI, sICH, and mortality compared to noncontrast CT selection alone.
REGISTRATION
URL: https://www.
CLINICALTRIALS
gov; Unique identifier: NCT04096248.

Identifiants

pubmed: 36252092
doi: 10.1161/STROKEAHA.122.039476
doi:

Banques de données

ClinicalTrials.gov
['NCT04096248']

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3594-3604

Auteurs

Fatih Seker (F)

Neuroradiology (F.S., M.A.M., ), Heidelberg University Hospital, Germany.

Muhammad M Qureshi (MM)

Radiology (M.M.Q., M.A., N.L.K., A.S., P.K., T.N.N.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Radiation Oncology (M.M.Q.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.

Markus A Möhlenbruch (MA)

Neuroradiology (F.S., M.A.M., ), Heidelberg University Hospital, Germany.

Raul G Nogueira (RG)

Neurology, University of Pittsburgh Medical Center, PA (R.G.N.).

Mohamad Abdalkader (M)

Radiology (M.M.Q., M.A., N.L.K., A.S., P.K., T.N.N.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.

Marc Ribo (M)

Neurology, Vall d'Hebron Research Institute, Vall D'Hebron University Hospital, Hospital Vall d'Hebron, Barcelona, Spain (M.R., M.O.-G.).

Francois Caparros (F)

University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France (F.C., H.H., C.C.).

Diogo C Haussen (DC)

Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA (D.C.H., M.H.M.).

Mahmoud H Mohammaden (MH)

Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA (D.C.H., M.H.M.).

Sunil A Sheth (SA)

Neurology, UTHealth McGovern Medical School, Houston, TX (S.A.S., S.S.-M.).

Santiago Ortega-Gutierrez (S)

Neurology, University of Iowa, Iowa City (S.O.-G., M.F.).

James E Siegler (JE)

Cooper Neurological Institute, Cherry Hill, NJ (J.E.S., A.R., T.G.J.).

Syed F Zaidi (SF)

Neurology, University of Toledo, OH (S.F.Z.' A.C.C.).

Marta Olive-Gadea (M)

Neurology, Vall d'Hebron Research Institute, Vall D'Hebron University Hospital, Hospital Vall d'Hebron, Barcelona, Spain (M.R., M.O.-G.).

Hilde Henon (H)

University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France (F.C., H.H., C.C.).

Alicia C Castonguay (AC)

Neurology, University of Toledo, OH (S.F.Z.' A.C.C.).

Stefania Nannoni (S)

Stroke Center, Department of Clinical Neurosciences, Department of Clinical Neurosciences' and Neurology Service' Lausanne University Hospital, University of Lausanne, Switzerland (S.N., P.M., D.S.).

Johannes Kaesmacher (J)

Diagnostic and Interventional Neuroradiology (J.K., J.G.), University Hospital Bern, Switzerland.
Interventional and Pediatric Radiology (J.K.), University Hospital Bern, Switzerland.

Ajit S Puri (AS)

Neurointerventional Radiology, University of Massachusetts, Worcester (A.S.P., A.L.K.).

Mudassir Farooqui (M)

Neurology, University of Iowa, Iowa City (S.O.-G., M.F.).

Sergio Salazar-Marioni (S)

Neurology, UTHealth McGovern Medical School, Houston, TX (S.A.S., S.S.-M.).

Anna L Kuhn (AL)

Neurointerventional Radiology, University of Massachusetts, Worcester (A.S.P., A.L.K.).

Nicole L Kiley (NL)

Radiology (M.M.Q., M.A., N.L.K., A.S., P.K., T.N.N.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.

Behzad Farzin (B)

Interventional Neuroradiology, Centre Hospitalier de l'Université de Montréal, Canada (B.F., W.B., J.R.).

William Boisseau (W)

Interventional Neuroradiology, Centre Hospitalier de l'Université de Montréal, Canada (B.F., W.B., J.R.).

Hesham E Masoud (HE)

Neurology, State University of New York, Upstate Medical University Hospital, Syracuse (H.E.M., C.Y.L.).

Carlos Ynigo Lopez (CY)

Neurology, State University of New York, Upstate Medical University Hospital, Syracuse (H.E.M., C.Y.L.).

Ameena Rana (A)

Cooper Neurological Institute, Cherry Hill, NJ (J.E.S., A.R., T.G.J.).

Samer Abdul Kareem (S)

Neuroscience, Bon Secours Mercy Health St. Vincent Hospital, Toledo, OH (S.A.K., M.W.K., O.O.Z.).

Anvitha Sathya (A)

Radiology (M.M.Q., M.A., N.L.K., A.S., P.K., T.N.N.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.

Piers Klein (P)

Radiology (M.M.Q., M.A., N.L.K., A.S., P.K., T.N.N.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.

Mohammad W Kassem (MW)

Neuroscience, Bon Secours Mercy Health St. Vincent Hospital, Toledo, OH (S.A.K., M.W.K., O.O.Z.).

Charlotte Cordonnier (C)

University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France (F.C., H.H., C.C.).

Jan Gralla (J)

Diagnostic and Interventional Neuroradiology (J.K., J.G.), University Hospital Bern, Switzerland.

Urs Fischer (U)

Neurology, University Hospital Bern, University of Bern, Switzerland (U.F.).
Neurology, University Hospital Basel, University of Basel, Switzerland (U.F.).

Patrik Michel (P)

Stroke Center, Department of Clinical Neurosciences, Department of Clinical Neurosciences' and Neurology Service' Lausanne University Hospital, University of Lausanne, Switzerland (S.N., P.M., D.S.).

Davide Strambo (D)

Stroke Center, Department of Clinical Neurosciences, Department of Clinical Neurosciences' and Neurology Service' Lausanne University Hospital, University of Lausanne, Switzerland (S.N., P.M., D.S.).

Tudor G Jovin (TG)

Cooper Neurological Institute, Cherry Hill, NJ (J.E.S., A.R., T.G.J.).

Jean Raymond (J)

Interventional Neuroradiology, Centre Hospitalier de l'Université de Montréal, Canada (B.F., W.B., J.R.).

Osama O Zaidat (OO)

Neuroscience, Bon Secours Mercy Health St. Vincent Hospital, Toledo, OH (S.A.K., M.W.K., O.O.Z.).

Peter A Ringleb (PA)

Neurology (P.A.R., S.N.), Heidelberg University Hospital, Germany.

Thanh N Nguyen (TN)

Radiology (M.M.Q., M.A., N.L.K., A.S., P.K., T.N.N.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Neurology (T.N.N.), Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, MA.

Simon Nagel (S)

Neurology (P.A.R., S.N.), Heidelberg University Hospital, Germany.
Neurology' Klinikum Ludwigshafen' Ludwigshafen A.R.' Germany (S.N.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH